Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Kedudukan dalam Saham #16729
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Harga Saham
$3.78
Disegerakkan terakhir: 2026-03-17
Modal Pasaran
$276.54M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
45.53%
Negara
CA
Perdagangan NervGen Pharma Corp. (NGEN)

Kategori

Sejarah pecahan saham untuk NervGen Pharma Corp. (NGEN)
Saham NervGen Pharma Corp. (simbol: NGEN) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Sep 02, 2026.
Satu saham NGEN yang dibeli sebelum Sep 02, 2026 kini bersamaan dengan 0 saham NGEN.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH